Capsule transplant for newly diagnosed type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 1 diabetes within the last 100 days
- Between 18 and 45 years old
- Body mass index (BMI) between 18 and 30
- Still making some insulin (C-peptide detectable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help improve blood sugar and thyroid antibody levels in people with type 2 diabetes and Hashimoto's thyroiditis. If you qualify, you might get a chance to try this new approach.
This trial tests whether taking capsules with healthy donor bacteria (fecal transplant) can help people who have severe diarrhea after surgery to remove part or all of the pancreas. The treatment aims to restore gut balance and reduce diarrhea.
This trial tests if a washed microbiota transplant (a processed stool transplant from healthy donors) can help people with type 1 diabetes. It aims to see if this treatment can improve blood sugar control or reduce the need for insulin.
This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.